| Serum Levels of Autoantibodies and the Risk of Non-Hodgkin Lymphoma and Multiple Myeloma |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0051 |
| Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0015 |
| Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer |
Mark Purdue |
DCEG, NCI |
PLCO |
Sep 18, 2020 |
2020-0003 |
| Serum levels of perfluorinated chemicals (PFCs) and aggressive prostate cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Mark Purdue |
NCI, DCEG |
PLCO |
Aug 3, 2017 |
2017-0031 |
| Serum Melatonin and Subsequent Risk of Prostate Cancer |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 17, 2009 |
2008-0256 |
| Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jiaqi Huang |
NIH |
PLCO |
Oct 23, 2018 |
2017-1017 |
| Serum metabolomic profiling of prostate cancer risk in black men |
Demetrius Albanes |
National Cancer Institute |
PLCO |
Jul 6, 2016 |
2016-0014 |
| Serum / plasma metabolomic profiling of vitamin supplement use |
Demetrius Albanes |
National Cancer Institute, NIH |
PLCO |
Nov 3, 2021 |
PLCO-849 |
| Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma |
Ola Landgren |
NCI, DCEG, GEB |
PLCO |
Jun 7, 2006 |
2005-0017 |
| Serum Sarcosine, Variation in Sarcosine-related Genes and Subsequent Risk of Prostate Cancer |
Stella Koutros |
NCI, DCEG, OEEB |
PLCO |
Dec 15, 2009 |
2009-0565 |
| Serum selenium and pancreatic cancer risk |
Rachael Stolzenberg - Solomon |
NCI, DCEG, NEB |
PLCO |
|
2007-0219 |
| Serum Testosterone and Subsequent Risk of Urologic and Non-Urologic Cancer |
Joshua Halpern |
Northwestern University Feinberg School of Medicine |
PLCO |
Sep 26, 2019 |
PLCO-528 |
| Serum trace and ultra-trace metals and pancreatic cancer |
Rachael Stolzenberg-Solomon |
NCI, DCEG, MEB |
PLCO |
Apr 27, 2012 |
2012-0035 |
| Serum Vitamin D and Risk of Bladder Cancer |
Alison Mondul |
NCI |
PLCO |
Sep 23, 2010 |
2010-0178 |
| Serum vitamin D binding protein and risk of renal cell carcinoma |
Alison Mondul |
University of Michigan |
PLCO |
Mar 7, 2014 |
2014-0027 |
| Sex hormones, hyperinsulinemia, and the risk of hematopoietic malignancies of the B-cell lineage |
Dean Hosgood |
Albert Einstein College of Medicine |
PLCO |
Aug 23, 2016 |
PLCO-221 |
| Sexually transmitted diseases and risk of head and neck cancer |
Anil Chaturvedi |
NCI, DCEG, IIB |
PLCO |
Mar 15, 2013 |
PLCO-20 |
| Sexually Transmitted Diseases (STDs) and Prostate Cancer |
Wen-Yi Huang |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0151 |
| Sharing PLCO oncoarray genotyping and covariate data with the African Ancestry Breast Cancer Consortium |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Jul 1, 2022 |
PLCO-1001 |
| SHBG Genetics |
Richard Hayes |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0133 |
